CHCHD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.160400E-01
Normal-vs-Stage2
2.812000E-01
Normal-vs-Stage3
1.897350E-01
Normal-vs-Stage4
8.215800E-01
Stage1-vs-Stage2
9.492400E-01
Stage1-vs-Stage3
2.791600E-01
Stage1-vs-Stage4
5.917200E-01
Stage2-vs-Stage3
1.056450E-01
Stage2-vs-Stage4
4.451200E-01
Stage3-vs-Stage4
1.177810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.986800E-01
Normal-vs-AfricanAmerican
5.798800E-01
Normal-vs-Asian
4.920400E-01
Caucasian-vs-AfricanAmerican
8.914400E-01
Caucasian-vs-Asian
7.137000E-01
AfricanAmerican-vs-Asian
7.506800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.073600E-01
Normal-vs-Female
3.791200E-01
Male-vs-Female
7.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.291800E-01
Normal-vs-Age(41-60Yrs)
3.871600E-01
Normal-vs-Age(61-80Yrs)
3.572800E-01
Normal-vs-Age(81-100Yrs)
5.742600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.974170E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.900800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.373600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.645000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.855600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.616600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.293810E-01
Normal-vs-Daily Drinker
5.833800E-01
Normal-vs-Weekly Drinker
2.039800E-01
Normal-vs-Occasional Drinker
8.199200E-01
Normal-vs-Social Drinker
6.922200E-01
Non Drinker-vs-Daily Drinker
1.125390E-01
Non Drinker-vs-Weekly Drinker
8.034000E-01
Non Drinker-vs-Occasional Drinker
9.418900E-03
Non Drinker-vs-Social Drinker
8.980100E-02
Daily Drinker-vs-Weekly Drinker
2.832000E-01
Daily Drinker-vs-Occasional Drinker
4.406400E-01
Daily Drinker-vs-Social Drinker
9.345000E-01
Weekly Drinker-vs-Occasional Drinker
4.661700E-02
Weekly Drinker-vs-Social Drinker
1.806170E-01
Occasional Drinker-vs-Social Drinker
3.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.263600E-01
Normal-vs-Grade 2
2.668000E-01
Normal-vs-Grade 3
2.319000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.845200E-01
Grade 1-vs-Grade 3
7.636400E-01
Grade 1-vs-Grade 4
4.263600E-01
Grade 2-vs-Grade 3
1.562380E-01
Grade 2-vs-Grade 4
2.668000E-01
Grade 3-vs-Grade 4
2.319000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.454800E-01
Normal-vs-NonDiabetic
3.304200E-01
Diabetic-vs-NonDiabetic
9.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.938400E-01
Normal-vs-NoPancreatitis
3.467600E-01
Pancreatitis-vs-NoPancreatitis
9.429600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.095800E-01
Normal-vs-N1
2.839800E-01
N0-vs-N1
1.490950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.968600E-01
Normal-vs-TP53-NonMutant
3.641400E-01
TP53-Mutant-vs-TP53-NonMutant
3.318400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
